The field of recombinant DNA technologies adapts nucleic acid amplification technology. INNAT is a simple method that efficiently and rapidly accumulates nucleic acid sequences at a constant temperature. Moreover, these techniques are developed as an alternative to a polymerase chain reaction. They are used for detecting and analyzing a small number of nucleic acids and biosensing targets such as DNA, RNA, cells, proteins, small molecules, and ions. It has been widely used in research, medicine, agriculture, and forensic. INAAT is preferred over PCR due to the low cost of equipment and fewer chances of contamination.
The isothermal nucleic acid amplification technology market size was valued at USD 1,729.0 million in 2019 and projected to grow at a CAGR of 13.8% during the forecast period, 2020-2027. The growing demand for INAAT is the primary factor due to the rising demand for molecular diagnostics and molecular testing techniques. Additionally, the increasing prevalence of infectious diseases such as HIV, Influenza, TB & other others, with rising demand for rapid diagnosis, will spur the global isothermal nucleic acid amplification technology in the future periods. Furthermore, the growing public-private funding for molecular diagnostics and the easy development of personalized medical products is expected to witness remarkable growth of isothermal technology. The increasing blood donations and rising numbers of blood transfusions are expected to propel the demand for INAAT over the coming years. Furthermore, the rise in the extensive R&D activities at the academic and industrial level and increasing scope of molecular testing are fueling the demand for INAAT in the healthcare market. Additionally, the growing geriatric population and growing healthcare demands in the developing world propelling the growth of the INAAT market across the globe.
INAAT is used in molecular diagnostics, which can provide quick and effective results. It has so many applications in the healthcare industry, from research to clinics, and is rapidly adapted over PCR due to removing contamination for adequate amplification and doesn’t require a thermocycler. Moreover, Due to the advantage of low cost &precise results, it has attracted various enterprises to the layout. Hence, owing to cost-benefit and novel technology, INAAT is expected to gain profit in the future. INAAT is manufactured for the rapid testing of various diseases causing agents, introducing newer pathogens, and the rising need for molecular diagnostics. However, the extensive usage of PCR over INAAT can be a restraint to the market of the INNAT industry.
Recently, the outbreak of COVID-19 has vigorously affected the healthcare system of developed and developing countries globally. The growing nervousness regarding the shortage of essential medical life-saving devices and other necessary medical supplies to shut out the spread of this virus and provide optimum care to the infected also widens. Additionally, the manufacturing process’s surge for broad assays kits, reagents, and others, will enhance the demand for INAAT in the healthcare industry.
The INNAT market is segregated into assays, kits & reagents, and Instruments or systems based on the product. The assay, kits, and reagents segment estimated to witness the highest growth over the analysis timeframe due to the increasing usage of diagnostics tests for infectious diseases in hospitals and diagnostics centers and the rising need for reagents in assay development and therapeutics.
The Instruments will grow significantly due to the rising adoption & utilization of isothermal technology and rapid expansion in the customer base.
The INAAT market is categorized into LAMP, SDA, NASBA, HAD, TMA, and other technologies based on the type of technology. The Transcription mediated amplification (TMA) segment held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the widespread use in molecular biology, forensics, and medicines for the rapid identification & diagnosis of pathogenic organisms and more reliability.
The HAD segment is poised to witness significant growth over the forecast period. It provides a rapid amplification method at an isothermic temperature and does not require a thermocycler.
Based on the application, the global INAAT market is classified into Infectious diseases diagnosis, blood screening, cancer, and other applications. The Infectious diseases diagnosis is expected to be the highest revenue share for INAAT during the forecast period. The segment’s hike is primarily attributed to the rising incidence of infectious diseases and increasing demand for rapid testing to prevent them from spreading.
The Blood screening will witness a lucrative growth rate in the estimated period due to the increasing number of blood transfusions and rising diseases such as anemia, cancer, hemophilia, and kidney diseases.
The global INAAT market is segmented into hospitals, reference laboratories, and academic & research institutes based on the end-user. The hospital & surgical centers segment will dominate the global INAAT market by 2027. Due to the rise in the number of hospitals & surgical centers using isothermal technology for diagnostic testing, economic expansion, and government focus on broader healthcare policies.
The reference laboratories accounted for the largest share of the INAAT market in 2019 because of the high adoption of accurate molecular diagnostics techniques for rapidly analyzing infectious diseases.
The global INAAT market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to project considerable growth over 2020-2026. It is owing to advents in technology, the presence of leading industry players offering innovative products, and increasing healthcare expenditure.
The Asia Pacific will generate a prominent share of the INAAT market by 2027. Due to the unmet clinical needs, we are continually expanding healthcare infrastructure in the region and mounting health care expenditures in growing countries such as India and China.
Companies such as Abbott Laboratories, Becton, BioMérieux SA, Dickinson & Company, DiaSorin S.p.A., Eikenchemical CO LTD, Hologic Inc, Grifols, Meridian Bioscience, Quidel Corporation, QIAGEN, Tecan Trading AG, Thermo Fisher Scientific Inc, GE Healthcare, and New England Biolabs are the key players in the global INAAT market.
By Product
By Technology Type
By Application
By End-User
By Region
Global INAAT Market
Analyst support
After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.
Customer satisfaction
According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.
Inimitable expertise
Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.
Assured quality
We have created a systematic way to determine standards and satisfy your expectations.
Instant delivery
Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.
Privacy policy
We understand the inkling of your privacy, we will never misuse your email address.
Custom research service
We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.
Quality & accuracy
We provide you with the accurate quality of the customized study of an exclusive report according to your research need.
Data visualization
As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.
Information security
We truly respect your privacy and promise to keep your personal and confidential information safe and secure.